MELANOMA, UVEAL METASTATIC

Clinical trials for MELANOMA, UVEAL METASTATIC explained in plain language.

Never miss a new study

Get alerted when new MELANOMA, UVEAL METASTATIC trials appear

Sign up with your email to follow new studies for MELANOMA, UVEAL METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New vaccine shows promise in rare eye cancer trial

Disease control Completed

This early-phase trial tested a personalized vaccine made from a patient's own immune cells and tumor material for metastatic uveal melanoma, a rare eye cancer. Seventeen adults received the vaccine alongside standard treatments like immunotherapy or chemotherapy. The main goals …

Matched conditions: MELANOMA, UVEAL METASTATIC

Phase: PHASE1 • Sponsor: Hasumi International Research Foundation • Aim: Disease control

Last updated May 08, 2026 12:03 UTC

MELANOMA, UVEAL METASTATIC

Get alerted when new MELANOMA, UVEAL METASTATIC trials appear

New vaccine shows promise in rare eye cancer trial